Trial Investigating the Characteristics of Knismesis - a Lever to Explore Allodynia in Neuropathic Pain

NCT ID: NCT04621747

Last Updated: 2021-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-23

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Also known as a "moving itch", knismesis is a mildly annoying sensation caused by a light movement on the skin, such as from a crawling insect. Its underlying mechanism rely on spatial summation, i.e. amplification of the signal due to summation of stimulated fields, like it is for dynamic allodynia in neuropathic pain. This physiological study aims at determining the physical factors of the cutaneous stimulation inducing knismesis as well as the effect of confounding factors. The main area of exploration will be the back, because of its size and the possibility to blind the participant. The information collected, along with animal data in surrogate models, would help to better understand neuropathic pain in the future.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a physiological proof-of-concept, also aiming to validate a functional exploration model in healthy volunteers. Each participant will undergo a battery if psychometric then psychophysics tests, presented sequentially. However, most of the main study tests (knismesis) will be admistered in a random order (crossover). The primary endpoint is to characterise, in the healthy human, the physical determinants of the cutaneous stimulation inducing knismesis: length of the pathway, speed, direction, intensity, continuity break of the contact, hairiness, body site, or distraction by other cutaneous stimuli. The secondary endpoint is to study the relationship between the individual sensitivity to spatial summation (knismesis) and other individual sensitivities or profiles.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Neurophysiology Psychophysics Sensory thresholds Neurons Pain, neuropathic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

healthy volunteers aged 18-35, balanced sex ratio, all of them undergoing the same battery of psychophysical explorations.

Group Type EXPERIMENTAL

Battery of neurophysiological explorations

Intervention Type OTHER

Visit 1: Biometry collection: gender, age, weight, height, eye colour.

* Questionnaires : the State and Trait Anxiety Inventory and the Pain Sensitivity
* Threshold of unpleasant light brightness, mechanical sensitivity threshold (von Frey hair).
* Training to estimate unpleasantness Under nociceptive and tickling stimuli, to use the handgrip.
* Mechanical pain threshold (electronic von Frey), heat pain threshold (Medoc Pathway).
* 48 stimulations applied to the back skin, following a predetermined plan with 12 different pathways, imbricated with 4 different speeds of movement.

Visit 2 (1 to 8 days later) :

* 42 stimulations applied to the back skin, to test the effect of stimulation intensity, the side of application, continuity break of the contact, and distraction by other cutaneous stimuli. The stimuli will follow the best paradigm as identified at the previous visit.
* 12 stimulations applied to forearm, cheeks, lower limbs, also testing the effect of hairiness.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Battery of neurophysiological explorations

Visit 1: Biometry collection: gender, age, weight, height, eye colour.

* Questionnaires : the State and Trait Anxiety Inventory and the Pain Sensitivity
* Threshold of unpleasant light brightness, mechanical sensitivity threshold (von Frey hair).
* Training to estimate unpleasantness Under nociceptive and tickling stimuli, to use the handgrip.
* Mechanical pain threshold (electronic von Frey), heat pain threshold (Medoc Pathway).
* 48 stimulations applied to the back skin, following a predetermined plan with 12 different pathways, imbricated with 4 different speeds of movement.

Visit 2 (1 to 8 days later) :

* 42 stimulations applied to the back skin, to test the effect of stimulation intensity, the side of application, continuity break of the contact, and distraction by other cutaneous stimuli. The stimuli will follow the best paradigm as identified at the previous visit.
* 12 stimulations applied to forearm, cheeks, lower limbs, also testing the effect of hairiness.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Ability to answer French questionnaires.

ยท BMI between 19 and 30 kg/m2 at inclusion.

Exclusion Criteria

* Pregnancy or breastfeeding.
* Natural intolerance to tickling.
* Any cutaneous, ocular or neurological disease contraindicating the psychophysical tests.
* Any disease or medical history that could expose the subject to unacceptable risk during the study.
* Any medication intake within 7 days before testing.
* History of drug or alcohol abuse.
* Involvement in another concomitant research protocol.
* Major dorsal hairiness.
* Inability to undergo the tests.
* Legal protection.
* Concomitant involvement in another clinical research.
* Refusal to participate.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NEURO-DOL (UMR 1107 INSERM / UCA)

UNKNOWN

Sponsor Role collaborator

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital, Clermont Ferrand

Clermont-Ferrand, Auvergne, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lise Laclautre

Role: CONTACT

Phone: 0473754963

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

lise laclautre

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RBHP 2020 DUALE

Identifier Type: -

Identifier Source: org_study_id